ylliX - Online Advertising Network
Company Ticker News

Atai Launches New “Nose-To-Brain” Drug Delivery Company To Interact With Its Portfolio Of Psychedelics Subsidiaries

Atai Launches New "Nose-To-Brain" Drug Delivery Company To Interact With Its Portfolio Of Psychedelics Subsidiaries

<script type="text/javascript" src="https://pppbr.com/bnr.php?section=Footer46860&pub=543549&format=728x90&ga=g&bg=1"></script>
<noscript><a href="https://yllix.com/publishers/543549" target="_blank"><img src="//ylx-aff.advertica-cdn.com/pub/728x90.png" style="border:none;margin:0;padding:0;vertical-align:baseline;" alt="ylliX - Online Advertising Network" /></a></noscript>

Atai Life Sciences (NASDAQ:ATAI) is launching a new company that will interact with its portfolio of psychedelics and tech start-ups looking at novel mental health treatments. InnarisBio Inc., as the company has been baptized, is being launched as a collaboration between Atai and UniQuest, a company managing and commercializing intellectual property developed by The University of Queensland in Australia.

...read full article on Benzinga

ylliX - Online Advertising Network